Signia Therapeutics announces an agreement with SANOFI to evaluate potential pipeline candidates LYON, FRANCE (November 1, 2018) Signia Therapeutics announced today that it has entered into an agreement with Sanofi to evaluate more than one hundred proprietary molecules from the Sanofi library. This agreement is a major milestone for Signia Therapeutics, and it will help … Continue reading Signia Therapeutics announces an agreement with SANOFI to evaluate potential pipeline candidates